 evidence

C (Low)

Quality of evidence

B (Moderate)

Journal of Vascular Surgery

Chaikof et al

7

Volume 67, Number 1

We suggest not administering statins, doxycycline, roxithromycin, ACE inhibitors, or angiotensin receptor
blockers for the sole purpose of reducing the risk of
AAA expansion and rupture.
Level of recommendation

2 (Weak)

Quality of evidence

C (Low